Home > Insider Trading > Filing (0001209191-12-053495)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1254419	Medassets Inc	MDAS	Services-Prepackaged Software (7372)	510391128

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1415811	A Rand Ballard	100 North Point Center East Suite 200 Alpharetta GA 30022	Chief Customer Officer	Yes	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Acquisiton	2012-11-14	44,800	$9.29	294,431	No	4	M	Direct
Common Stock	Acquisiton	2012-11-14	7,285	$9.68	301,716	No	4	M	Direct
Common Stock	Disposition	2012-11-14	37,482	$16.09	264,234	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	M	Direct
No	4	M	Direct
No	4	S	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Stock Options (Right to Buy)	Disposition	2012-11-14	20,000	$0.00	20,000	$9.29
Common Stock	Stock Options (Right to Buy)	Disposition	2012-11-14	24,800	$0.00	24,800	$9.29
Common Stock	Stock Options (Right to Buy)	Disposition	2012-11-14	7,285	$0.00	7,285	$9.68

Remaning Holdings	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
0	2017-09-10	No	4	M	Direct
0	2017-09-10	No	4	M	Direct
6,604	2016-10-01	No	4	M	Direct

Reported Derivative Holdings

Sec. Name	Sec. Type	Price	Expiration Date	Amount	Remaning Holdings	Nature of Ownership
Common Stock	Stock Options (Right to Buy)	$9.68	2016-07-05	11,996	11,996	Direct
Common Stock	Stock Options (Right to Buy)	$15.95	2018-03-25	15,082	15,082	Direct
Common Stock	Stock-Settled Stock Appreciation Rights	$14.74	2016-01-05	88,166	88,166	Direct

Expiration Date	Amount	Remaning Holdings	Nature of Ownership
2016-07-05	11,996	11,996	Direct
2018-03-25	15,082	15,082	Direct
2016-01-05	88,166	88,166	Direct

Footnotes

The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 14, 2007.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $16.00 to $16.35, inclusive. The reporting person undertakes to provide to MedAssets, Inc., any security holder of MedAssets, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
The reporting person was granted these stock options on September 10, 2007 and are fully vested.
The reporting person was granted these stock options on October 1, 2006 and are fully vested.
The reporting person was granted these stock options on July 5, 2006 and are fully vested.
The reporting person was granted these stock options on March 25, 2008. The stock options vest equally (over the course of 60 months) on the first day of each month beginning on March 1, 2008, such that 100% of the stock options will be fully vested on February 1, 2013.
The reporting person was granted these stock-settled stock appreciation rights (SSARs) on January 5, 2009. The SSARs vest 25% annually beginning on December 31, 2009 such that 100% of the SSARs will be fully vested on December 31, 2012.